ECONOMIC BURDEN OF ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS HARBORING KRASG12C MUTATION IN SPAIN

被引：0
|
作者：
Fernandez-Barcelo, C. [1 ]
Abbas, I
Botella, X. [2 ]
Aguilo Domingo, M. [2 ]
Cots, F. [3 ]
Siles Cuesta, C. [3 ]
Arriola, E. [3 ]
Gas Lopez, M. E. [4 ]
Lopez Gomez, C. [4 ]
Juan-Vidal, O. [5 ]
Planellas, L. [6 ]
Lloansi, A. [6 ]
Sanchez, J. [1 ]
Reguart, N. [1 ]
Sampietro-Colom, L. [1 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Consorci Sanitari Terrassa, Terrassa, Spain
[3] Hosp Mar CIBERONC, Barcelona, Spain
[4] Hlth Res Inst Hosp La Fe, Valencia, Spain
[5] Hosp La Fe Valencia, Valencia, Spain
[6] Amgen SA, Barcelona, Spain
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD89
引用
收藏
页码：S521 / S521
页数：1
相关论文
共 50 条
  • [1] Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation
    Jaenne, Pasi A.
    Riely, Gregory J.
    Gadgeel, Shirish M.
    Heist, Rebecca S.
    Ou, Sai-Hong I.
    Pacheco, Jose M.
    Johnson, Melissa L.
    Sabari, Joshua K.
    Leventakos, Konstantinos
    Yau, Edwin
    Bazhenova, Lyudmila
    Negrao, Marcelo V.
    Pennell, Nathan A.
    Zhang, Jun
    Anderes, Kenna
    Der-Torossian, Hirak
    Kheoh, Thian
    Velastegui, Karen
    Yan, Xiaohong
    Christensen, James G.
    Chao, Richard C.
    Spira, Alexander I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (02) : 120 - 131
  • [2] Characterization of patients with advanced non-small-cell lung cancer (NSCLC) harboring KRASG12C mutation and their associated direct healthcare costs in Spanish routine clinical practice (SILK study)
    Aransay, N. Reguart
    Sanchez, J.
    Vidal, O. J. Juan
    Domingo, M. Aguilo
    Arriola, E.
    Lopez, C.
    Botella, X.
    Cots, F.
    Montironi, C.
    Palanca, S.
    Borras, E.
    Pinto, L. Masfarre
    Planellas, L.
    Vila, A. Lloansi
    ANNALS OF ONCOLOGY, 2023, 34
  • [3] First Approval of Adagrasib for the Treatment of Non-Small Cell Lung Cancer Harboring a KRASG12C Mutation
    De, Surya K.
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (03) : 266 - 272
  • [4] KRYSTAL-7: Efficacy and safety of adagrasib with pembrolizumab in patients with treatment-naive, advanced non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation
    Garassino, M. C.
    Theelen, W. S. M. E.
    Jotte, R.
    Laskin, J.
    De Marinis, F.
    Aguado, C.
    Badin, F. B.
    Chmielewska, I.
    Hochmair, M. J.
    Lu, S.
    Nadal, E.
    Ostoros, G.
    Felip, E.
    Spira, A. I.
    Lane, C. M.
    He, J.
    Chao, R.
    Janne, P. A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1309 - S1310
  • [5] Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments
    Torres-Jimenez, Javier
    Espinar, Javier Baena
    de Cabo, Helena Bote
    Berjaga, Maria Zurera
    Esteban-Villarrubia, Jorge
    Fraile, Jon Zugazagoitia
    Paz-Ares, Luis
    DRUGS, 2024, 84 (05) : 527 - 548
  • [6] KRYSTAL-12: Phase 3 study of adagrasib versus docetaxel in patients with previously treated advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation
    Mok, Tony S. K.
    Yao, Wenxiu
    Duruisseaux, Michael
    Doucet, Ludovic
    Azkarate Martinez, Aitor
    Gregorc, Vanesa
    Juan-Vidal, Oscar
    Lu, Shun
    De Bondt, Charlotte
    de Marinis, Filippo
    Linardou, Helena
    Kim, Young-Chul
    Jotte, Robert M.
    Felip, Enriqueta
    Lo Russo, Giuseppe
    Reck, Martin
    Michenzie, Mary F.
    Yang, Wenjing
    Meade, Julie N.
    Barlesi, Fabrice
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA8509 - LBA8509
  • [7] KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation.
    Spira, Alexander I.
    Riely, Gregory J.
    Gadgeel, Shirish M.
    Heist, Rebecca Suk
    Ou, Sai-Hong Ignatius
    Pacheco, Jose Maria
    Johnson, Melissa Lynne
    Sabari, Joshua K.
    Leventakos, Konstantinos
    Yau, Edwin
    Bazhenova, Lyudmila
    Negrao, Marcelo Vailati
    Pennell, Nathan A.
    Zhang, Jun
    Velastegui, Karen
    Christensen, James G.
    Yan, Xiaohong
    Anderes, Kenna Lynn
    Chao, Richard C.
    Janne, Pasi A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Adagrasib in Advanced Solid Tumors Harboring a KRASG12C Mutation
    Bekaii-Saab, Tanios S.
    Yaeger, Rona
    Spira, Alexander I.
    Pelster, Meredith S.
    Sabari, Joshua K.
    Hafez, Navid
    Barve, Minal
    Velastegui, Karen
    Yan, Xiaohong
    Shetty, Aditya
    Der-Torossian, Hirak
    Pant, Shubham
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (25) : 4097 - +
  • [9] Phase I study of D-1553 to assess safety and efficacy in patients with non-small cell lung cancer (NSCLC) harboring KRASG12C mutation.
    Jian, Hong
    Song, Zhenbo
    Zhang, Yiping
    Li, Kunyan
    Yang, Nong
    Moore, Melissa
    Wang, Pingli
    Zhao, Yanqiu
    Gong, Yi
    Underhill, Craig
    Kim, Sang-We
    Yang, Cheng-Ta
    Xiang, Ziyong
    Shi, Zhe
    Zhang, Ling
    Wang, Yaolin
    Lu, Shun
    CANCER RESEARCH, 2022, 82 (12)
  • [10] The Prevalence and Concurrent Pathogenic Mutations of KRASG12C in Northeast Chinese Non-small-cell Lung Cancer Patients
    Liu, Yan
    Li, Hui
    Zhu, Jing
    Zhang, Yang
    Liu, Xianhong
    Li, Rixin
    Zhang, Qiang
    Cheng, Ying
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2447 - 2454
12345